IMMX
Immix Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.00
-0.11 ▼ -1.09%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$10.00
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -0.79 | Insider Own | 24.92% | Shs Outstand | 0.05B | Perf Week | 7.64% |
| Market Cap | 0.53B | Forward P/E | - | EPS next Y | -50.22% | Insider Trans | 0.05% | Shs Float | 0.04B | Perf Month | 46.2% |
| Enterprise Value | 0.51B | PEG | - | EPS next Q | -0.16 | Inst Own | 44.46% | Short Float | 7.47% | Perf Quarter | 48.59% |
| Income | -0.02B | P/S | - | EPS this Y | 22.11% | Inst Trans | 87.55% | Short Ratio | 3.34 | Perf Half Y | 350.45% |
| Sales | 0.00B | P/B | 39.97 | EPS next 5Y | - | ROA | -104.21% | Short Interest | 2.97M | Perf YTD | 91.2% |
| Book/sh | 0.25 | P/C | 33.2 | EPS past 3/5Y | 25.44% -43.61% | ROE | -182.55% | 52W High | -6.63% ($10.71) | Perf Year | 532.91% |
| Cash/sh | 0.3 | P/FCF | - | Sales past 3/5Y | - | ROIC | -255.28% | 52W Low | 646.27% ($1.34) | Perf 3Y | 385.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 10.2% | Gross Margin | - | Volatility(W/M) | 8.32% 8.14% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.53 | EPS Q/Q | 2.22% | Profit Margin | - | RSI (14) | 70.37 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.53 | Sales Q/Q | - | SMA20 | 14.29% ($8.75) | Beta | 0.18 | Target Price | $16.33 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/02/25 | SMA50 | 46.1% ($6.84) | Rel Volume | 0.68 | Prev Close | $10.11 |
| Employees | 21 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -14.97% - | SMA200 | 148.04% ($4.03) | Avg Volume(3M) | 0.89M | Price | $10 |
| IPO | 2021/12/16 | Option/Short | Yes/Yes | Trades | 7780 | Volume | 607,698 | Change | -1.09% |
뉴스 로딩 중...